BlackRock
MTEM

BlackRock’s Molecular Templates, Inc. MTEM Stock Holding History

BlackRock’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-38,130
Closed -$53.6K – 5530
2024
Q3 		$53.6K Hold
38,130
– – ﹤0.01% 4800
2024
Q2 		$43.9K Sell
38,130
-1,511
-4% -$2.24K ﹤0.01% 4891
2024
Q1 		$88.8K Sell
39,641
-4
-0% -$13 ﹤0.01% 4760
2023
Q4 		$148K Hold
39,645
– – ﹤0.01% 4712
2023
Q3 		$251K Sell
39,645
-168
-0.4% -$1.33K ﹤0.01% 4619
2023
Q2 		$287K Sell
39,813
-10,074
-20% -$68.8K ﹤0.01% 4637
2023
Q1 		$284K Sell
49,887
-3,941
-7% -$26.6K ﹤0.01% 4690
2022
Q4 		$265K Sell
53,828
-22,335
-29% -$185K ﹤0.01% 4773
2022
Q3 		$856K Sell
76,163
-1,010
-1% -$12.7K ﹤0.01% 4532
2022
Q2 		$1.05M Sell
77,173
-111,610
-59% -$2.61M ﹤0.01% 4513
2022
Q1 		$9.77M Sell
188,783
-1,277
-0.7% -$56.4K ﹤0.01% 3589
2021
Q4 		$11.2M Buy
190,060
+15,221
+9% +$1.14M ﹤0.01% 3607
2021
Q3 		$17.6M Sell
174,839
-2,088
-1% -$215K ﹤0.01% 3372
2021
Q2 		$20.8M Sell
176,927
-27,187
-13% -$3.56M ﹤0.01% 3276
2021
Q1 		$38.6M Sell
204,114
-1,133
-0.6% -$199K ﹤0.01% 2793
2020
Q4 		$28.9M Buy
205,247
+8,804
+4% +$1.3M ﹤0.01% 2811
2020
Q3 		$32.2M Buy
196,443
+17,892
+10% +$3.18M ﹤0.01% 2565
2020
Q2 		$36.9M Buy
178,551
+15,593
+10% +$3.62M ﹤0.01% 2426
2020
Q1 		$32.5M Buy
162,958
+29,500
+22% +$6.46M ﹤0.01% 2331
2019
Q4 		$28M Buy
133,458
+59,653
+81% +$8.57M ﹤0.01% 2695
2019
Q3 		$7.3M Buy
73,805
+1,768
+2% +$165K ﹤0.01% 3364
2019
Q2 		$9.02M Buy
72,037
+24,357
+51% +$2.65M ﹤0.01% 3304
2019
Q1 		$4.15M Sell
47,680
-1,913
-4% -$140K ﹤0.01% 3470
2018
Q4 		$3M Buy
49,593
+10,349
+26% +$722K ﹤0.01% 3550
2018
Q3 		$3.17M Buy
39,244
+613
+2% +$47K ﹤0.01% 3631
2018
Q2 		$3.03M Buy
38,631
+28,950
+299% +$3.28M ﹤0.01% 3615
2018
Q1 		$1.16M Sell
9,681
-36
-0.4% -$5.42K ﹤0.01% 3837
2017
Q4 		$1.46M Buy
9,717
+16
+0.2% +$2.01K ﹤0.01% 3791
2017
Q3 		$1.01M Buy
9,701
+24
+0.2% +$2.07K ﹤0.01% 3907
2017
Q2 		$627K Sell
9,677
-1,133
-10% -$89.1K ﹤0.01% 3963
2017
Q1 		$1.02M Buy
+10,810
New +$1.01M ﹤0.01% 3810
2016
Q2 		– Sell
-9
Closed -$1K – 3849
2016
Q1 		$1K Hold
9
– – ﹤0.01% 3584
2015
Q4 		$1K Sell
9
-16
-64% -$7.89K ﹤0.01% 3406
2015
Q3 		$17K Buy
25
+16
+178% +$11.4K ﹤0.01% 2486
2015
Q2 		$6K Hold
9
– – ﹤0.01% 3087
2015
Q1 		$6K Hold
9
– – ﹤0.01% 2992
2014
Q4 		$5K Hold
9
– – ﹤0.01% 3079
2014
Q3 		$5K Hold
9
– – ﹤0.01% 3086
2014
Q2 		$6K Hold
9
– – ﹤0.01% 3084
2014
Q1 		$7K Hold
9
– – ﹤0.01% 2951
2013
Q4 		$7K Hold
9
– – ﹤0.01% 2941
2013
Q3 		$7K Hold
9
– – ﹤0.01% 2872
2013
Q2 		$8K Buy
+9
New +$7.61K ﹤0.01% 2791

Other funds holding MTEM

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock's MTEM Position: Q4 2024 in Review

BlackRock sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 38,130 shares — an estimated $53.6K sold.

BlackRock first reported a position in MTEM in Q2 2013 and held it in 43 quarters. The position peaked at $38.6M in Q1 2021. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

  • BlackRock reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
  • BlackRock sold 38,130 Molecular Templates, Inc. shares in Q4 2024, an estimated $53.6K.
  • BlackRock first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 43 quarters.
  • BlackRock's Molecular Templates, Inc. position peaked at $38.6M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on BlackRock's 13F filing for Q4 2024, filed 7 Feb 2025.